Stockreport

Celularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an Appeal

Celularity Inc. - Class A  (CELU) 
PDF FLORHAM PARK, N.J., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”), a regenerative medicine company developing and commercializing pl [Read more]